Silence Therapeutics Plc has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan is an associate professor of medicine at the University of Warwick and a consultant physician at University Hospitals. He trained in medicine at Guy’s and King’s in London and completed specialist training at University College London, Middlesex and Whittington Hospitals.
Dr Khan has held numerous research grants in cell and molecular biology. He and his co-workers have also made important contributions to the further understanding of cancer cell biology and diabetes, Silence said in a statement issued on 18 September 2012.
Copyright 2012 Evernow Publishing Ltd